Fingerprint
Dive into the research topics of 'Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting
NET CTPM participants
- Sunnybrook Health Sciences Centre
- University of California at San Francisco
- Memorial Sloan-Kettering Cancer Center
- University of Iowa
- Dana-Farber Cancer Institute
- University of Texas MD Anderson Cancer Center
- University of Miami
- AstraZeneca
- National Institutes of Health
- Moffitt Cancer Center
- Icahn School of Medicine at Mount Sinai
- Primary Children's Medical Center
- University of Utah
- Yale University
- Ipsen
- Genentech Incorporated
- Genentech US Medical Affairs
- Nanu
- Vanderbilt University
- The EMMES Corporation
- Cornell University
- United States Food and Drug Administration
- Leidos Inc
- University of Colorado
- Advanced Accelerator Applications
- Cedars-Sinai Medical Center
- Peter Maccallum Cancer Centre
- Johns Hopkins
- University of Toronto
- Mayo Clinic
- Roswell Park Comprehensive Cancer Center
- Sarah Cannon Research Institute
- Boston University
- NorCal CarciNET Community
- Novartis
- Stanford University
- Friedrich-Alexander University Erlangen-Nürnberg
- Exelixis Inc.
- University of Florida
- University of Pennsylvania
- ITM
- Princess Margaret Cancer Centre
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations